GSK-GLP114130

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment

Medicine or Vaccine (generic name)

albiglutide

Sponsor Identification Number

GLP114130

Trial Registry Identification Number(#'s)

NCT01098539 2010-019777-15

Medical Condition

Diabetes Mellitus, Type 2

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=114130

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01098539

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-019777-15

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format

Date Added to this Site

November 2014